Autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells CT053

{
  "id": "MLC-T-ONC-011342",
  "term": "Autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells CT053",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that have been transduced with a vector expressing a chimeric antigen receptor (CAR) containing a humanized single chain variable fragment (scFv) specific for the tumor-associated antigen (TAA) B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) that is fused to the co-stimulatory domain of 4-1BB (CD137) and the T-cell receptor signaling domain of CD3zeta (CD3z), with potential immunostimulating and antineoplastic activities. Upon administration, the autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells CT053 specifically recognize and induce selective toxicity against BCMA-expressing tumor cells. BCMA, a tumor-specific antigen and a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and plays a key role in the survival of B lymphocytes and plasma cells. BCMA is found on the surfaces of B cells and is overexpressed on malignant plasma cells.",
  "synonyms": [
    "CAR-BCMA T cells CT053",
    "anti-BCMA-CAR-41BB-CD3zeta-expressing T cells CT053",
    "BCMA Car-T (CT053)",
    "CT053 CAR-BCMA T",
    "CT053 CAR-BCMA T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053/"
}